- Home
- RLMD vs PSTV Comparison
RLMD vs PSTV Comparison
Compare RLMD & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- PSTV
- Stock Information
- Founded
- RLMD 2004
- PSTV 1996
- Country
- RLMD United States
- PSTV United States
- Employees
- RLMD N/A
- PSTV N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- PSTV Medical/Dental Instruments
- Sector
- RLMD Health Care
- PSTV Health Care
- Exchange
- RLMD Nasdaq
- PSTV Nasdaq
- Market Cap
- RLMD 11.5M
- PSTV 12.2M
- IPO Year
- RLMD N/A
- PSTV N/A
- Fundamental
- Price
- RLMD $0.40
- PSTV $0.47
- Analyst Decision
- RLMD Hold
- PSTV Strong Buy
- Analyst Count
- RLMD 4
- PSTV 3
- Target Price
- RLMD $4.25
- PSTV $12.75
- AVG Volume (30 Days)
- RLMD 4.5M
- PSTV 3.1M
- Earning Date
- RLMD 05-12-2025
- PSTV 05-23-2025
- Dividend Yield
- RLMD N/A
- PSTV N/A
- EPS Growth
- RLMD N/A
- PSTV N/A
- EPS
- RLMD N/A
- PSTV N/A
- Revenue
- RLMD N/A
- PSTV $5,824,000.00
- Revenue This Year
- RLMD N/A
- PSTV $13.26
- Revenue Next Year
- RLMD N/A
- PSTV $8.84
- P/E Ratio
- RLMD N/A
- PSTV N/A
- Revenue Growth
- RLMD N/A
- PSTV 18.54
- 52 Week Low
- RLMD $0.24
- PSTV $0.24
- 52 Week High
- RLMD $4.47
- PSTV $2.67
- Technical
- Relative Strength Index (RSI)
- RLMD 51.73
- PSTV 39.86
- Support Level
- RLMD $0.36
- PSTV $0.48
- Resistance Level
- RLMD $0.44
- PSTV $0.75
- Average True Range (ATR)
- RLMD 0.08
- PSTV 0.10
- MACD
- RLMD -0.00
- PSTV -0.00
- Stochastic Oscillator
- RLMD 26.98
- PSTV 5.95
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).